NEW YORK ─ Calgary, Canada-based Health Logic Interactive said on Monday that its subsidiary My Health Logic has entered into an exclusive agreement to license lab-on-a-chip technology from the University of Manitoba that has the potential to be used in a handheld device to provide rapid diagnosis of chronic kidney disease at the point of care and in people's homes.
The technology, called UAL-Chip, could accelerate the trend toward automation, digitization, and personalization in the healthcare industry, Health Logic said. It uses microfluidic technology to test for levels of albumin in urine and deliver rapid results to a user's smartphone and healthcare practitioner.
"Bringing the CKD diagnosis into the home is a disruptive approach that could bridge the screening gap for millions of patients," Claudio Rigatto, coinventor of the lab-on-a-chip technology at Seven Oaks General Hospital, said in a statement.
Financial and other terms of the license agreement were not disclosed.